Gilead Sciences Inc. (GILD) News Nov 20, 2014, 6:5
Post# of 250663
Posted On: 11/20/2014 7:20:39 PM
Gilead Sciences Inc. (GILD) News Nov 20, 2014, 6:58 p.m.
MarketWatch News on GILD
Gilead Sciences shares slide 1.7% 9:35 a.m. Nov. 19, 2014 - Sue Chang
Are consumers getting gouged on health care? 12:58 p.m. Nov. 18, 2014 - Russ Britt
The double-edged sword of growth-stock speculation 2:29 p.m. Nov. 14, 2014 - The Trading Deck
10 S&P 500 companies with the fastest revenue growth 8:28 a.m. Nov. 11, 2014 - Philip van Doorn
Merck, Dendreon miss out on health-care rally 12:39 p.m. Nov. 10, 2014 - Russ Britt
Gilead Sciences rises 2% to top S&P 500 gainers 9:31 a.m. Nov. 10, 2014 - Sue Chang
Visa shares rise after hours on earnings beat 6:50 p.m. Oct. 29, 2014 - Sue Chang
Warren Buffett best wear his trunks as Fed preps to end (pause) the printing 8:34 a.m. Oct. 29, 2014 - Shawn Langlois
Facebook, Gilead shares fall after hours 6:14 p.m. Oct. 28, 2014 - Sue Chang
Updates, advisories and surprises 5:01 p.m. Oct. 28, 2014 - MarketWatch
Sales of Gilead's pricey hepatitis C drug slow 4:26 p.m. Oct. 28, 2014 - MarketWatch.com
Gilead Sciences' stock pulls back from record high close after earnings miss 4:14 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead's stock drops 3.6% in after-hours trade after Q3 results 4:09 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead revises 2014 product sales outlook to $22 bln-$23 bln from $21 bln-$23 bln 4:08 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 Sovaldi sales $2.8 bln vs. $3.48 bln in Q2 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 sales top FactSet consensus estimate of $5.99 bln 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 sales $6.04 bln vs. $2.78 bln a year ago 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 net EPS $1.67 vs. 47 cents a year ago 4:06 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Sciences Q3 adj. EPS $1.84 vs. FactSet consensus $1.92 4:06 p.m. Oct. 28, 2014 - Tomi Kilgore
Two biotech leaders to watch 2:12 p.m. Oct. 28, 2014 - The Trading Deck
Other News on GILD
Gilead to Buy Knight Therapeutics' Priority Review Voucher - Analyst Blog 4:27 p.m. Today - Zacks.com
France gets larger discount on Sovaldi than its neighbors 12:04 p.m. Today - Seeking Alpha
Global drug tab will breach trillion dollar mark this year 7:41 a.m. Today - Seeking Alpha
CNBC's Stock Pops & Drops From November 19 6:38 a.m. Today - benzinga.com
Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog 5:57 p.m. Nov. 19, 2014 - Zacks.com
Why We're Huge Fans Of Gilead 4:33 p.m. Nov. 19, 2014 - Seeking Alpha
Gilead buys FDA voucher for $125M 3:59 p.m. Nov. 19, 2014 - Seeking Alpha
Gilead: Pipeline Now Includes Potential Renal Blockbuster 11:35 a.m. Nov. 19, 2014 - Seeking Alpha
Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog 11:23 a.m. Nov. 19, 2014 - Zacks.com
Update: Gilead's Harvoni Receives Marketing Authorization In Europe 11:17 a.m. Nov. 19, 2014 - Seeking Alpha
Stock Market News for November 19, 2014 - Market News 10:10 a.m. Nov. 19, 2014 - Zacks.com
Stock Market Today: Oil Slump Fuels S&P 500 to Fresh Record High 4:09 p.m. Nov. 18, 2014 - TheStreet.com
Gilead's Value Without Its Hep C Franchise 4:07 p.m. Nov. 18, 2014 - Seeking Alpha
Stock Market Today: S&P 500 Notches New High as Oil Prices Slip and Slide 2:23 p.m. Nov. 18, 2014 - TheStreet.com
Stock Movers: Why 4 Big Drug Stocks Are Rising Today 1:38 p.m. Nov. 18, 2014 - Investors Business Daily
Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for Harvoni 10:48 a.m. Nov. 18, 2014 - TheStreet.com
Buy Gilead Sciences Now At A Historic Low Valuation 8:52 a.m. Nov. 18, 2014 - Seeking Alpha
Dispelling Some Of The Myths Surrounding Gilead Sciences. 8:22 a.m. Nov. 18, 2014 - Seeking Alpha
Trade of the Day: Gilead Sciences (GILD) 3:16 a.m. Nov. 18, 2014 - InvestorPlace.com
Trade of the Day: Gilead Sciences Stock on Sale 7:56 p.m. Nov. 17, 2014 - InvestorPlace.com
Press Releases on GILD
Earnings Forecast Report for Yahoo, Alibaba, Cliffs Natural Resources, Gilead Sciences, Apple, and Plug Power 8:45 a.m. Today - PR Newswire - PRF
Knight Sells Priority Review Voucher to Gilead 5:11 p.m. Nov. 19, 2014 - Marketwired
European Commission Grants Marketing Authorization for Gilead’s Harvoni®▼ (Ledipasvir/Sofosbuvir), the First Single Tablet Regimen to Treat the Majority of Chronic Hepatitis C Patients With Genotype 1 and 4 10:07 a.m. Nov. 18, 2014 - BusinessWire - BZX
Earnings Forecast Buzz for Baker Hughes, Halliburton, Apple, Gilead Sciences, Kinder Morgan, and Alibaba 8:45 a.m. Nov. 18, 2014 - PR Newswire - PRF
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene 9:10 a.m. Nov. 14, 2014 - PR Newswire - PRF
Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com 8:45 a.m. Nov. 14, 2014 - PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes 5:59 p.m. Nov. 12, 2014 - BusinessWire - BZX
Earnings Forecast Recap for Alibaba, Apple, Zynga, Gilead Sciences, Dendreon, and Juniper 8:45 a.m. Nov. 12, 2014 - PR Newswire - PRF
Gilead Announces Phase 2 Data for Investigational All-Oral Regimen of Sofosbuvir Plus GS-5816 for the Treatment of Chronic Hepatitis C 8:02 a.m. Nov. 11, 2014 - BusinessWire - BZX
Gilead Announces Harvoni Study Results in Chronic Hepatitis C Patients with Advanced Liver Disease and Those Who Failed Prior Treatment 8:02 a.m. Nov. 11, 2014 - BusinessWire - BZX
Earnings Forecast Buzz for Alibaba, Genworth Financial, Gilead Sciences, Zynga, Abercrombie & Fitch, and Plug Power 8:45 a.m. Nov. 10, 2014 - PR Newswire - PRF
Medifocus to Be Broadcast on BNN and Fox Business News on November 8th and 9th, 2014 10:56 a.m. Nov. 7, 2014 - Marketwired
Linkage Biosciences Adds to Board Leadership 8:02 a.m. Nov. 7, 2014 - Marketwired
Critical Alerts For Delta Airlines, ConocoPhillips, Qualcomm, Kinder Morgan and Gilead Sciences Released By InvestorsObserver 9:31 a.m. Nov. 6, 2014 - PR Newswire - PRF
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Tenofovir Alafenamide (TAF)-Based Single Tablet Regimen for HIV 8:32 a.m. Nov. 6, 2014 - BusinessWire - BZX
Earnings Forecast Buzz for Alibaba, GT Advanced Technologies, GoPro, Plug Power, Gilead Sciences, and American Realty Capital Properties 8:45 a.m. Nov. 4, 2014 - PR Newswire - PRF
Life-Science New Build Report: 200 New North American Sites in Planning Represent Potential $15 Billion Investment, an Industrial Info News Alert 6:16 a.m. Nov. 4, 2014 - Marketwired
Gilead Sciences Once Again Tops the List of California's Most Honored Companies in Institutional Investor's All-America Executive Team Ranking 6:15 a.m. Nov. 4, 2014 - Marketwired
Earnings Forecast Buzz for American Realty Capital Properties, Alibaba, Petroleo Brasileiro Petrobras SA, Gilead Sciences, RF Micro Devices, and GoPro 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly 8:35 a.m. Oct. 29, 2014 - PR Newswire - PRF
MarketWatch News on GILD
Gilead Sciences shares slide 1.7% 9:35 a.m. Nov. 19, 2014 - Sue Chang
Are consumers getting gouged on health care? 12:58 p.m. Nov. 18, 2014 - Russ Britt
The double-edged sword of growth-stock speculation 2:29 p.m. Nov. 14, 2014 - The Trading Deck
10 S&P 500 companies with the fastest revenue growth 8:28 a.m. Nov. 11, 2014 - Philip van Doorn
Merck, Dendreon miss out on health-care rally 12:39 p.m. Nov. 10, 2014 - Russ Britt
Gilead Sciences rises 2% to top S&P 500 gainers 9:31 a.m. Nov. 10, 2014 - Sue Chang
Visa shares rise after hours on earnings beat 6:50 p.m. Oct. 29, 2014 - Sue Chang
Warren Buffett best wear his trunks as Fed preps to end (pause) the printing 8:34 a.m. Oct. 29, 2014 - Shawn Langlois
Facebook, Gilead shares fall after hours 6:14 p.m. Oct. 28, 2014 - Sue Chang
Updates, advisories and surprises 5:01 p.m. Oct. 28, 2014 - MarketWatch
Sales of Gilead's pricey hepatitis C drug slow 4:26 p.m. Oct. 28, 2014 - MarketWatch.com
Gilead Sciences' stock pulls back from record high close after earnings miss 4:14 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead's stock drops 3.6% in after-hours trade after Q3 results 4:09 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead revises 2014 product sales outlook to $22 bln-$23 bln from $21 bln-$23 bln 4:08 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 Sovaldi sales $2.8 bln vs. $3.48 bln in Q2 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 sales top FactSet consensus estimate of $5.99 bln 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 sales $6.04 bln vs. $2.78 bln a year ago 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 net EPS $1.67 vs. 47 cents a year ago 4:06 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Sciences Q3 adj. EPS $1.84 vs. FactSet consensus $1.92 4:06 p.m. Oct. 28, 2014 - Tomi Kilgore
Two biotech leaders to watch 2:12 p.m. Oct. 28, 2014 - The Trading Deck
Other News on GILD
Gilead to Buy Knight Therapeutics' Priority Review Voucher - Analyst Blog 4:27 p.m. Today - Zacks.com
France gets larger discount on Sovaldi than its neighbors 12:04 p.m. Today - Seeking Alpha
Global drug tab will breach trillion dollar mark this year 7:41 a.m. Today - Seeking Alpha
CNBC's Stock Pops & Drops From November 19 6:38 a.m. Today - benzinga.com
Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog 5:57 p.m. Nov. 19, 2014 - Zacks.com
Why We're Huge Fans Of Gilead 4:33 p.m. Nov. 19, 2014 - Seeking Alpha
Gilead buys FDA voucher for $125M 3:59 p.m. Nov. 19, 2014 - Seeking Alpha
Gilead: Pipeline Now Includes Potential Renal Blockbuster 11:35 a.m. Nov. 19, 2014 - Seeking Alpha
Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog 11:23 a.m. Nov. 19, 2014 - Zacks.com
Update: Gilead's Harvoni Receives Marketing Authorization In Europe 11:17 a.m. Nov. 19, 2014 - Seeking Alpha
Stock Market News for November 19, 2014 - Market News 10:10 a.m. Nov. 19, 2014 - Zacks.com
Stock Market Today: Oil Slump Fuels S&P 500 to Fresh Record High 4:09 p.m. Nov. 18, 2014 - TheStreet.com
Gilead's Value Without Its Hep C Franchise 4:07 p.m. Nov. 18, 2014 - Seeking Alpha
Stock Market Today: S&P 500 Notches New High as Oil Prices Slip and Slide 2:23 p.m. Nov. 18, 2014 - TheStreet.com
Stock Movers: Why 4 Big Drug Stocks Are Rising Today 1:38 p.m. Nov. 18, 2014 - Investors Business Daily
Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for Harvoni 10:48 a.m. Nov. 18, 2014 - TheStreet.com
Buy Gilead Sciences Now At A Historic Low Valuation 8:52 a.m. Nov. 18, 2014 - Seeking Alpha
Dispelling Some Of The Myths Surrounding Gilead Sciences. 8:22 a.m. Nov. 18, 2014 - Seeking Alpha
Trade of the Day: Gilead Sciences (GILD) 3:16 a.m. Nov. 18, 2014 - InvestorPlace.com
Trade of the Day: Gilead Sciences Stock on Sale 7:56 p.m. Nov. 17, 2014 - InvestorPlace.com
Press Releases on GILD
Earnings Forecast Report for Yahoo, Alibaba, Cliffs Natural Resources, Gilead Sciences, Apple, and Plug Power 8:45 a.m. Today - PR Newswire - PRF
Knight Sells Priority Review Voucher to Gilead 5:11 p.m. Nov. 19, 2014 - Marketwired
European Commission Grants Marketing Authorization for Gilead’s Harvoni®▼ (Ledipasvir/Sofosbuvir), the First Single Tablet Regimen to Treat the Majority of Chronic Hepatitis C Patients With Genotype 1 and 4 10:07 a.m. Nov. 18, 2014 - BusinessWire - BZX
Earnings Forecast Buzz for Baker Hughes, Halliburton, Apple, Gilead Sciences, Kinder Morgan, and Alibaba 8:45 a.m. Nov. 18, 2014 - PR Newswire - PRF
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene 9:10 a.m. Nov. 14, 2014 - PR Newswire - PRF
Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com 8:45 a.m. Nov. 14, 2014 - PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes 5:59 p.m. Nov. 12, 2014 - BusinessWire - BZX
Earnings Forecast Recap for Alibaba, Apple, Zynga, Gilead Sciences, Dendreon, and Juniper 8:45 a.m. Nov. 12, 2014 - PR Newswire - PRF
Gilead Announces Phase 2 Data for Investigational All-Oral Regimen of Sofosbuvir Plus GS-5816 for the Treatment of Chronic Hepatitis C 8:02 a.m. Nov. 11, 2014 - BusinessWire - BZX
Gilead Announces Harvoni Study Results in Chronic Hepatitis C Patients with Advanced Liver Disease and Those Who Failed Prior Treatment 8:02 a.m. Nov. 11, 2014 - BusinessWire - BZX
Earnings Forecast Buzz for Alibaba, Genworth Financial, Gilead Sciences, Zynga, Abercrombie & Fitch, and Plug Power 8:45 a.m. Nov. 10, 2014 - PR Newswire - PRF
Medifocus to Be Broadcast on BNN and Fox Business News on November 8th and 9th, 2014 10:56 a.m. Nov. 7, 2014 - Marketwired
Linkage Biosciences Adds to Board Leadership 8:02 a.m. Nov. 7, 2014 - Marketwired
Critical Alerts For Delta Airlines, ConocoPhillips, Qualcomm, Kinder Morgan and Gilead Sciences Released By InvestorsObserver 9:31 a.m. Nov. 6, 2014 - PR Newswire - PRF
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Tenofovir Alafenamide (TAF)-Based Single Tablet Regimen for HIV 8:32 a.m. Nov. 6, 2014 - BusinessWire - BZX
Earnings Forecast Buzz for Alibaba, GT Advanced Technologies, GoPro, Plug Power, Gilead Sciences, and American Realty Capital Properties 8:45 a.m. Nov. 4, 2014 - PR Newswire - PRF
Life-Science New Build Report: 200 New North American Sites in Planning Represent Potential $15 Billion Investment, an Industrial Info News Alert 6:16 a.m. Nov. 4, 2014 - Marketwired
Gilead Sciences Once Again Tops the List of California's Most Honored Companies in Institutional Investor's All-America Executive Team Ranking 6:15 a.m. Nov. 4, 2014 - Marketwired
Earnings Forecast Buzz for American Realty Capital Properties, Alibaba, Petroleo Brasileiro Petrobras SA, Gilead Sciences, RF Micro Devices, and GoPro 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly 8:35 a.m. Oct. 29, 2014 - PR Newswire - PRF
(0)
(0)